**Core Concept**
The electron transport chain (ETC) is a crucial process in cellular respiration, where electrons are passed through a series of protein complexes to generate ATP. Complex I, also known as NADH dehydrogenase, is the first enzyme in the ETC and plays a vital role in the process. Its inhibition can have significant effects on cellular energy production.

**Why the Correct Answer is Right**
The correct answer is a compound that directly inhibits Complex I of the ETC. This inhibition occurs through the binding of the compound to the flavin mononucleotide (FMN) or iron-sulfur clusters within the enzyme. As a result, the flow of electrons is disrupted, leading to a decrease in the production of ATP. The inhibition of Complex I has been implicated in various diseases, including neurodegenerative disorders and cancer.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not directly inhibit Complex I of the ETC. Instead, it targets a different component of the electron transport chain.
* **Option B:** This option is not a known inhibitor of Complex I. It may have other effects on cellular metabolism, but it is not a specific inhibitor of this enzyme.
* **Option C:** This option is incorrect because it actually activates Complex I, rather than inhibiting it.

**Clinical Pearl / High-Yield Fact**
One of the key clinical implications of Complex I inhibition is its association with neurodegenerative disorders, such as Parkinson's disease. The inhibition of Complex I can lead to the accumulation of reactive oxygen species, which can damage dopaminergic neurons and contribute to the development of the disease.

**Correct Answer: B. Rotenone**